Exicure, Inc. Share Price
NASDAQ: XCUR | Micro CapExicure, Inc. Stock Performance
Exicure, Inc. Share Price Today
As of 29 October 2026, Exicure, Inc.'s share price is $1.06. The stock opened at $1.08, compared to its previous close of $1.10. During today's trading session, Exicure, Inc.'s share price traded between $1.05 and $1.10, with an average price of $1.08. Over the past 52 weeks, the stock has recorded a high of $9.38 and a low of $0.97. In terms of performance, Exicure, Inc.'s share price has declined by 69.63% over the last six months and is down 77.11% on a year-on-year basis.
Exicure, Inc. Share Price Chart
Exicure, Inc. Quarterly Profit & Loss
All figures in USD
Exicure, Inc. Annual Profit & Loss
All figures in USD
About Exicure, Inc.
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.
Exicure, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.05 | $1.06 | -15.20% |
Sep 2026 | $1.34 | $1.25 | -11.97% |
Aug 2026 | $1.57 | $1.42 | -15.98% |
Jul 2026 | $1.98 | $1.69 | -14.65% |
Jun 2026 | $3.10 | $1.98 | -37.34% |
May 2026 | $3.25 | $3.16 | -9.46% |
Apr 2026 | $3.75 | $3.49 | -21.04% |
Mar 2026 | $3.79 | $4.42 | +17.87% |
Feb 2026 | $4.22 | $3.75 | -7.86% |
Jan 2026 | $5.48 | $4.07 | -26.67% |
Dec 2025 | $4.70 | $5.55 | +33.41% |
Nov 2025 | $4.31 | $4.16 | -10.15% |